RecalledThisWeek Search
Low risk Drugs & MedicationsClass III

Cipla Diclofenac Sodium Topical Gel Recall

Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX

Updated December 22, 2025

Cipla's Diclofenac Sodium Topical Gel 1% (100 g) is being recalled because it failed pH specifications, which may affect the product's stability and effectiveness.

Is the Cipla USA, Inc. recalled? Yes. This product was recalled by FDA on December 22, 2025. Details below.

What is recalled

Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), NDC 76282-103-39, manufactured by DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215, and distributed under the Cipla USA, Inc. brand.

Am I affected

You're affected if you own a tube or container of Diclofenac Sodium Topical Gel 1% with NDC 76282-103-39 manufactured by DPT Laboratories, Ltd.

What to do right now

Stop using this product. Contact Cipla USA, Inc. or the place where you purchased it for instructions on return or replacement.

The hazard

Failed PH Specifications

Brands affected

Cipla USA, Inc.
Source
FDA
Category
Drugs & Medications
Recall ID
fda-D-0291-2026
Classification
Class III
Recalled
December 22, 2025
Read the official notice

Get free recall alerts

New Drugs & Medications recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Drugs & Medications recalls